American Healthcare REIT (AHR) Expected to Announce Earnings on Thursday

American Healthcare REIT (NYSE:AHR) will likely be announcing its Q4 2025 results after the market closes on Thursday, February 26th. Analysts expect American Healthcare REIT to post earnings of $0.46 per share and revenue of $617.4890 million for the quarter. Interested persons can check the company’s upcoming Q4 2025 earning summary page for the latest details on the call scheduled for Friday, February 27, 2026 at 1:00 PM ET.

American Healthcare REIT Trading Down 0.5%

AHR opened at $52.43 on Wednesday. The company has a quick ratio of 0.44, a current ratio of 0.44 and a debt-to-equity ratio of 0.37. The stock’s fifty day moving average is $48.53 and its two-hundred day moving average is $45.93. The company has a market capitalization of $9.28 billion, a P/E ratio of 374.53, a PEG ratio of 2.00 and a beta of 1.03. American Healthcare REIT has a 52 week low of $26.48 and a 52 week high of $53.10.

American Healthcare REIT Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, January 16th. Investors of record on Wednesday, December 31st were issued a $0.25 dividend. This represents a $1.00 annualized dividend and a dividend yield of 1.9%. The ex-dividend date was Wednesday, December 31st. American Healthcare REIT’s payout ratio is presently 714.29%.

Wall Street Analysts Forecast Growth

A number of research firms have commented on AHR. Scotiabank raised their target price on shares of American Healthcare REIT from $47.00 to $55.00 and gave the company a “sector outperform” rating in a research report on Thursday, November 13th. Citizens Jmp reissued a “market outperform” rating and issued a $60.00 price objective on shares of American Healthcare REIT in a research note on Thursday, February 5th. KeyCorp upped their target price on American Healthcare REIT from $43.00 to $55.00 and gave the stock an “overweight” rating in a report on Thursday, November 13th. UBS Group lifted their price target on American Healthcare REIT from $51.00 to $56.00 and gave the company a “buy” rating in a report on Monday, November 17th. Finally, BMO Capital Markets started coverage on American Healthcare REIT in a research report on Thursday, January 29th. They issued an “outperform” rating and a $55.00 price target for the company. One equities research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, American Healthcare REIT currently has an average rating of “Moderate Buy” and an average target price of $52.00.

Insider Transactions at American Healthcare REIT

In related news, Director Jeffrey T. Hanson sold 35,570 shares of the company’s stock in a transaction dated Monday, December 22nd. The stock was sold at an average price of $48.38, for a total transaction of $1,720,876.60. Following the transaction, the director directly owned 19,208 shares of the company’s stock, valued at $929,283.04. This represents a 64.93% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. 1.00% of the stock is owned by corporate insiders.

Institutional Trading of American Healthcare REIT

Several large investors have recently bought and sold shares of the stock. AQR Capital Management LLC raised its holdings in shares of American Healthcare REIT by 170.1% in the first quarter. AQR Capital Management LLC now owns 25,275 shares of the company’s stock worth $766,000 after buying an additional 15,918 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in shares of American Healthcare REIT by 4.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 90,521 shares of the company’s stock valued at $2,743,000 after buying an additional 3,954 shares during the last quarter. NewEdge Advisors LLC increased its position in shares of American Healthcare REIT by 9.4% in the 1st quarter. NewEdge Advisors LLC now owns 23,509 shares of the company’s stock valued at $712,000 after acquiring an additional 2,011 shares during the period. Focus Partners Wealth raised its stake in American Healthcare REIT by 6.6% in the 1st quarter. Focus Partners Wealth now owns 25,809 shares of the company’s stock worth $782,000 after acquiring an additional 1,591 shares during the last quarter. Finally, Acadian Asset Management LLC purchased a new position in American Healthcare REIT in the 1st quarter worth $185,000. Hedge funds and other institutional investors own 16.68% of the company’s stock.

American Healthcare REIT Company Profile

American Healthcare REIT, Inc (NYSE: AHR) was a publicly traded real estate investment trust focused on acquiring, owning and managing healthcare‐related properties across the United States. The company’s portfolio spanned senior housing communities, skilled nursing facilities, medical office buildings and outpatient care centers, all operated under long‐term net lease or triple‐net lease structures designed to provide stable, predictable rental income.

Employing a strategy of partnering with established healthcare operators, American Healthcare REIT targeted properties in both major metropolitan areas and high‐growth secondary markets to capitalize on demographic trends such as an aging population and increased demand for outpatient services.